Yantai Dongcheng Beifang Pharmaceutical

Yantai Dongcheng Beifang Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer and a wholly-owned subsidiary of the Yantai Dongcheng Pharmaceutical Group. Established in 1993 and based in Yantai, China, the company focuses on the production of high-quality injectable drugs, including freeze-dried powder injections and pre-filled small-volume injections. Its core therapeutic focus includes anticoagulation, reproductive health, and anti-inflammatory treatments. The company's flagship product, Bailishu (Nadroparin Calcium), is a leading brand in the Chinese low-molecular-weight heparin market. With advanced GMP-certified facilities, Yantai Dongcheng Beifang Pharmaceutical serves as a critical production hub for the group's finished dosage forms.